Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Anat Ashkenazi
Pharma
Lilly is taking a hard line with its buzzy diabetes med Mounjaro
Amid supply squeezes and mainstream hype for injectable incretin meds, Eli Lilly is trying to run a tight ship on its dual GIP/GLP-1 launch Mounjaro.
Fraiser Kansteiner
Feb 2, 2023 11:18am
Lilly warns of supply constraints amid demand for two key meds
Nov 1, 2022 10:43am
Lilly CFO exits, forfeits $24M after 'inappropriate' behavior
Feb 9, 2021 8:11am